Bessemer Group’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.91M	Hold	481,790	–	–	0.01%	342
2025 Q1	$5.31M	Buy	+481,790	New	+$5.31M	0.01%	346